DE60330442D1 - Als atm-inhibitoren geeignete pyranone - Google Patents

Als atm-inhibitoren geeignete pyranone

Info

Publication number
DE60330442D1
DE60330442D1 DE60330442T DE60330442T DE60330442D1 DE 60330442 D1 DE60330442 D1 DE 60330442D1 DE 60330442 T DE60330442 T DE 60330442T DE 60330442 T DE60330442 T DE 60330442T DE 60330442 D1 DE60330442 D1 DE 60330442D1
Authority
DE
Germany
Prior art keywords
pyranone
inhibitors suitable
atm inhibitors
sulfonamino
acylamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330442T
Other languages
English (en)
Inventor
Graeme C M Smith
Niall M B Martin
Stephen P Jackson
Mark J O'connor
Alan Y K Lau
Xiao-Ling Fan Cockcroft
Ian Timothy Will Matthews
Keith Allan Menear
Laurent Jean Rigoreau
Marc Geoffrey Hummersone
Roger John Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kudos Pharmaceuticals Ltd
Original Assignee
Kudos Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0204350.3A external-priority patent/GB0204350D0/en
Application filed by Kudos Pharmaceuticals Ltd filed Critical Kudos Pharmaceuticals Ltd
Application granted granted Critical
Publication of DE60330442D1 publication Critical patent/DE60330442D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60330442T 2002-02-25 2003-02-24 Als atm-inhibitoren geeignete pyranone Expired - Lifetime DE60330442D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0204350.3A GB0204350D0 (en) 2002-02-25 2002-02-25 ATM inhibitors
US39588402P 2002-07-15 2002-07-15
PCT/GB2003/000770 WO2003070726A1 (en) 2002-02-25 2003-02-24 Pyranones useful as atm inhibitors

Publications (1)

Publication Number Publication Date
DE60330442D1 true DE60330442D1 (de) 2010-01-21

Family

ID=27758841

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330442T Expired - Lifetime DE60330442D1 (de) 2002-02-25 2003-02-24 Als atm-inhibitoren geeignete pyranone

Country Status (20)

Country Link
EP (2) EP2174939A1 (de)
JP (1) JP2005521689A (de)
CN (1) CN100358891C (de)
AT (1) ATE451365T1 (de)
AU (1) AU2003209990B8 (de)
BR (1) BR0307944A (de)
CA (1) CA2473100A1 (de)
CY (1) CY1109835T1 (de)
DE (1) DE60330442D1 (de)
DK (1) DK1485377T5 (de)
ES (1) ES2336206T3 (de)
GB (1) GB2401606B (de)
HK (1) HK1069827A1 (de)
MX (1) MXPA04007809A (de)
NO (1) NO329806B1 (de)
NZ (1) NZ534821A (de)
PL (1) PL370074A1 (de)
PT (1) PT1485377E (de)
SI (1) SI1485377T1 (de)
WO (1) WO2003070726A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
US7122189B2 (en) * 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
US7413738B2 (en) 2002-08-13 2008-08-19 Enzon Pharmaceuticals, Inc. Releasable polymeric conjugates based on biodegradable linkers
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US20070099186A1 (en) * 2003-05-01 2007-05-03 D Adda Di Fagagna Fabrizio Methods and means for the treatment of disorders associated with cellular senescence
DE602004026071D1 (de) 2003-08-13 2010-04-29 Kudos Pharm Ltd Aminopyrone und ihre verwendung als atm inhibitoren
TWI338000B (en) 2003-12-01 2011-03-01 Kudos Pharm Ltd Dna damage repair inhibitors for treatment of cancer
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
BRPI0515498A (pt) 2004-09-20 2008-07-29 Kudos Pharm Ltd inibidores de dna-pk
TW200638938A (en) * 2005-02-09 2006-11-16 Kudos Pharm Ltd ATM inhibitors
AR054438A1 (es) 2005-04-15 2007-06-27 Kudos Pharm Ltd Inhibidores de adn -pk
UY29774A1 (es) * 2005-08-31 2007-03-30 Kudos Pharm Ltd Inhibidor de atm
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
WO2009034326A1 (en) 2007-09-14 2009-03-19 Astrazeneca Ab Phthalazinone derivatives
CN102238945B (zh) 2008-10-07 2014-10-29 阿斯利康(英国)有限公司 药物制剂514
EP2486923B1 (de) * 2011-02-11 2015-09-09 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Histon-Deacetylase (HDAC) hemmende Verbindungen und Verfahren zu deren Herstellung
AU2012275841A1 (en) 2011-06-27 2014-01-16 The Jackson Laboratory Methods and compositions for treatment of cancer and autoimmune disease
EP3042900B1 (de) * 2013-08-29 2020-09-23 Fujifilm Corporation Neuartige morpholinderivate oder salz davon
EP4171651A1 (de) 2020-06-24 2023-05-03 AstraZeneca UK Limited Kombination aus antikörper-wirkstoff-konjugat und atm-inhibitor
CN112094210A (zh) * 2020-09-24 2020-12-18 江苏扬农化工股份有限公司 一种取代的亚磺酸盐的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
EP0331250B1 (de) * 1988-03-02 1994-04-13 Merck & Co. Inc. Antihypercholesterolemisches Mittel
JPH05501886A (ja) * 1990-06-29 1993-04-08 ジ・アップジョン・カンパニー 抗アテローム性動脈硬化症性および抗血栓性２―アミノ―６―フェニル―４ｈ―ピラン―４―オン類
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
JP3851661B2 (ja) * 1996-05-14 2006-11-29 第一製薬株式会社 新規生理活性物質及びその製造方法
FR2765579A1 (fr) * 1997-07-01 1999-01-08 Lipha Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones leurs preparations et leurs utilisations comme rodonticides
DE69833952T2 (de) * 1997-09-26 2006-12-07 Toray Industries, Inc. Zyklische ketonderivate und ihre pharmazeutische verwendung
DE69917237T2 (de) * 1998-03-12 2005-05-04 Teijin Ltd. Benzofurylpyron-derivate

Also Published As

Publication number Publication date
CN1639154A (zh) 2005-07-13
NZ534821A (en) 2006-07-28
BR0307944A (pt) 2005-02-01
PL370074A1 (en) 2005-05-16
AU2003209990A1 (en) 2003-09-09
CA2473100A1 (en) 2003-08-28
EP1485377B1 (de) 2009-12-09
NO20044063L (no) 2004-09-24
ATE451365T1 (de) 2009-12-15
EP1485377A1 (de) 2004-12-15
GB0419534D0 (en) 2004-10-06
DK1485377T3 (da) 2010-04-19
JP2005521689A (ja) 2005-07-21
AU2003209990B2 (en) 2008-10-09
ES2336206T3 (es) 2010-04-09
GB2401606A (en) 2004-11-17
HK1069827A1 (en) 2005-06-03
GB2401606B (en) 2005-08-31
EP1485377B8 (de) 2010-02-24
ES2336206T9 (es) 2011-03-24
MXPA04007809A (es) 2004-10-15
EP1485377B9 (de) 2010-10-06
SI1485377T1 (sl) 2010-04-30
CN100358891C (zh) 2008-01-02
CY1109835T1 (el) 2014-09-10
EP2174939A1 (de) 2010-04-14
WO2003070726A1 (en) 2003-08-28
DK1485377T5 (da) 2010-12-06
NO329806B1 (no) 2010-12-20
PT1485377E (pt) 2010-03-12
AU2003209990B8 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
HK1069827A1 (en) Pyranones useful as atm inhibitors.
ZA200601595B (en) Aminopyrones and their use as ATM inhibitors
BR0316241A (pt) Pirrolobenzodiazepinas
MEP61208A (en) Novel compounds having inhibitory activity against sodium-dependant transporter
RS20060315A (en) Derivatives of n-/phenyl(pyrrolidine-2-yl) methyl/benzamide, and n- /(azepan-2-yl)phenylmethyl/benzamide, preparation method thereof and application of same in therapeutics
UY26727A1 (es) Derivados de tropano útiles en terapia
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
UA88329C2 (en) Dna-pk inhibitors
EA200000400A1 (ru) Галогензамещенные тетрациклические производные тетрагидрофурана
RS51193B (sr) Hidantoinski derivati korisni kao inhibitori metaloproteinaza
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
DE602007004740D1 (de) Antibiotische spiroderivate
CO5580821A2 (es) 4-cetolactamas y -lactonas 3-fenil-3-substituidas, espirociclicas
RS51320B (sr) Derivati imidazohinolina kao veznici a3 receptora adenozina
AR057558A1 (es) Compuestos de cinolincarboxamida y composicion farmaceutica
ATE550332T1 (de) 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors
ES2064057T3 (es) Unos derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos, su preparacion y su aplicacion en terapeutica.
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
UY26568A1 (es) Nuevos derivados de amidas heterocíclicas
ATE500243T1 (de) Carbonsäureamidverbindung und deren verwendung
EA199800083A1 (ru) Производные 1,3-оксазин-4-она в качестве гербицидов
IL178548A (en) Derivatives of 14,15-dihydro 20,21-dinoreburnamenin-14-ol and applications thereof
TR200402333T4 (tr) Artropodisidal karboksanilidler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition